Filippo Acconcia

Filippo Acconcia

Sep 19, 2017

Group 6 Copy 13
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Living Skin Therapeutics

One of the biggest roadblocks to having clear skin is acne, and despite all the effective treatment options...

Can a Meal Replacement Help Solve Hunger in America?

In the United States, hunger is commonplace. 42 million Americans struggle to get the healthy foods they need...

Does Zika virus replicate in neural cells?

Zika virus is a rapidly emerging virus that is spreading throughout the Western Hemisphere. It is predicted...

Campaign Ended